![David A. Bristol](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David A. Bristol
Directeur/Bestuurslid bij HCF Enterprises, Inc.
Actieve functies van David A. Bristol
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HCF Enterprises, Inc. | Directeur/Bestuurslid | - | - |
Sentinel Private Equity XVI Fund | Directeur/Bestuurslid | - | - |
Loopbaan van David A. Bristol
Eerdere bekende functies van David A. Bristol
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Exxon Co. USA | Corporate Officer/Principal | 02-01-1991 | 02-01-1991 |
Nanospectra Biosciences, Inc.
![]() Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Directeur/Bestuurslid | 28-07-2011 | - |
Opleiding van David A. Bristol
Brown University | Undergraduate Degree |
The University of Texas at Austin | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Nanospectra Biosciences, Inc.
![]() Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
HCF Enterprises, Inc. | |
Exxon Co. USA | |
Sentinel Private Equity XVI Fund |
- Beurs
- Insiders
- David A. Bristol
- Ervaring